Gilead Sciences

Vice President, Analytical Development

Foster City, California, United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical Sciences, Pharmaceutical DevelopmentIndustries

Requirements

The Vice President, Analytical Development requires a Bachelor’s degree in a scientific discipline, such as Chemistry, Biology, or Pharmaceutical Sciences, and possesses at least 15 years of experience in analytical development, with a strong preference for experience in the pharmaceutical industry. A Ph.D. in a relevant scientific field is highly desirable, and demonstrated leadership experience within a large, complex organization is expected.

Responsibilities

This role involves providing strategic and technical direction across the entire product lifecycle, overseeing analytical method development and characterization, ensuring data integrity, setting strategies and developing long-range plans for all modalities, and aligning analytical control strategies with regulatory strategies. The Vice President will also lead analytical team leads, oversee data generation, and serve as a member of the Technical Development Leadership Team, ultimately driving alignment of near-term deliverables and long-range plans across PDM functions.

Skills

Analytical Method Development
Method Characterization
Data Integrity
Regulatory Strategies
Strategic Planning
Leadership
Team Leadership
Pharmaceutical Industry
Modality Development

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Key Metrics

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI